Phase I evaluation of the safety and pharmacokinetics of a single-dose intravenous injection of a murine monoclonal antibody against Hantaan virus in healthy volunteers. [electronic resource]
Producer: 20100201Description: 5055-9 p. digitalISSN:- 1098-6596
No physical items for this record
Publication Type: Clinical Trial, Phase I; Journal Article; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.